Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Tron

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 12, 2017
Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trialChristian Hengstenberg, Jaya Chandrasekhar, Samantha Sartori, et al.
European Heart Journal. Cardiovascular Imaging|April 23, 2024
Tricuspid annular plane systolic excursion over systolic pulmonary artery pressure prognostic value for in-hospital adverse events in patients hospitalized for acute coronary syndromeCharles Fauvel, Jean-Guillaume Dillinger, Claire Bouleti, et al.
The American Journal of Cardiology|December 25, 2012
Diagnostic performance of computed tomography coronary angiography (from the Prospective National Multicenter Multivendor EVASCAN Study)Pascal Gueret, Jean-François Deux, Laurent Bonello, et al.
Journal of the American College of Cardiology|October 20, 2015
Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 TrialGeorge D Dangas, Thierry Lefèvre, Christian Kupatt, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 23, 2019
Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO-3 randomized trialDavid Power, Ulrich Schäfer, Paul Guedeney, et al.
The New England Journal of Medicine|September 1, 2015
Cyclosporine before PCI in Patients with Acute Myocardial InfarctionThien-Tri Cung, Olivier Morel, Guillaume Cayla, et al.
American Heart Journal|June 2, 2015
Rationale and design of the Cyclosporine to ImpRove Clinical oUtcome in ST-elevation myocardial infarction patients (the CIRCUS trial)Nathan Mewton, Thien T Cung, Olivier Morel, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 12, 2017
Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trialChristian Hengstenberg, Jaya Chandrasekhar, Samantha Sartori, et al.
European Heart Journal. Cardiovascular Imaging|April 23, 2024
Tricuspid annular plane systolic excursion over systolic pulmonary artery pressure prognostic value for in-hospital adverse events in patients hospitalized for acute coronary syndromeCharles Fauvel, Jean-Guillaume Dillinger, Claire Bouleti, et al.
The American Journal of Cardiology|December 25, 2012
Diagnostic performance of computed tomography coronary angiography (from the Prospective National Multicenter Multivendor EVASCAN Study)Pascal Gueret, Jean-François Deux, Laurent Bonello, et al.
Journal of the American College of Cardiology|October 20, 2015
Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 TrialGeorge D Dangas, Thierry Lefèvre, Christian Kupatt, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 23, 2019
Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO-3 randomized trialDavid Power, Ulrich Schäfer, Paul Guedeney, et al.
The New England Journal of Medicine|September 1, 2015
Cyclosporine before PCI in Patients with Acute Myocardial InfarctionThien-Tri Cung, Olivier Morel, Guillaume Cayla, et al.
American Heart Journal|June 2, 2015
Rationale and design of the Cyclosporine to ImpRove Clinical oUtcome in ST-elevation myocardial infarction patients (the CIRCUS trial)Nathan Mewton, Thien T Cung, Olivier Morel, et al.
Pageof 7